Michael King
Stock Analyst at EF Hutton
(0)
# 4725
Out of 5,218 analysts
132
Total ratings
31.30%
Success rate
-20.32%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Apollomics | Maintains: Buy | 1100 650 | 8.35 | 7684.43% | 4 | Apr 1, 2024 | |
Sonnet BioTherapeuti... | Assumes: Buy | 1180 | 1.86 | 63297.85% | 7 | Aug 23, 2023 | |
Lantern Pharma | Reiterates: Buy | 11 | 3.46 | 217.92% | 10 | Aug 10, 2023 | |
Biomea Fusion | Reiterates: Buy | 32 | 5.64 | 467.38% | 11 | Jun 26, 2023 | |
Jasper Therapeutics | Reiterates: Buy | 69 | 20.51 | 233.98% | 10 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 10 | n/a | n/a | 7 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 9 | 1.66 | 400% | 6 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 862 | 730.7 | 17.97% | 11 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 24 | 35.01 | -31.45% | 10 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 17 | 0.65 | 2515.38% | 3 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 166 | 3.03 | 5378.55% | 7 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 42 | 24.05 | 74.64% | 5 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 304 | 245.25 | 23.96% | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 123 116 | 12.89 | 799.92% | 6 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 11 | 1.46 | 605.48% | 2 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 28 | 0.19 | 14636.84% | 2 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 24 | 42.06 | -42.94% | 1 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 1000 800 | 1.48 | 53954.05% | 2 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 43 46 | 15.6 | 194.87% | 3 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 98 96 | 39.09 | 145.59% | 6 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10500 5250 | n/a | n/a | 2 | Jan 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 36 | 0.98 | 3573.47% | 1 | Jan 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | 0.64 | 1775% | 1 | Dec 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 31 | 8.22 | 277.13% | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 9 | n/a | n/a | 1 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 180 160 | 0.21 | 76090.48% | 4 | Oct 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 1088 544 | n/a | n/a | 2 | Jun 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 33 36 | 606.64 | -94.07% | 2 | Nov 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Outperform | 38 | n/a | n/a | 1 | Oct 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Aug 29, 2017 |